Do you want to read an article? Please log in or register.
Technical systematic review supporting 2025 AASLD Practice Guidelines on management of chronic hepatitis B
Hepatitis
RECOMMENDED
Related content
RECOMMENDED
Hepatitis
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis B
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Hepatology
Ghany MG, Pan CQ, Lok AS, Feld JJ, Lim JK, Wang SH, Kim AY, Tang AS, Nguyen MH, Naggie S, Sulkowski MS, Rodriguez-Baez N, Chen J, Murad MH, Mohammad KS, Terrault NA
doi: 10.1097/HEP.0000000000001549
Hepatitis
Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis
Lancet Gastroenterol Hepatol
Stockdale AJ, Holt B, Bhadoria AS, Sadasivan A, Ikeda D, Pollack T, Ong JP, Pham T, Duong DB, Nguyen V, Ndow G, Chou R, Easterbrook P
doi: 10.1016/S2468-1253(25)00163-3
Hepatitis
Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-analysis
Clin Gastroenterol Hepatol
Islam AH, Alvizuri C, Desalegn H, Stephenson E, Idalsoaga F, Diaz LA, MacDonald JK, Im GY, Singal AK, Jairath V, Khan MQ, Arab JP
doi: 10.1016/j.cgh.2025.05.016
Hepatitis
EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection
Gut
Tang S, Huang T, Tang R, Lin K, Luo C, Shen Y, Zhang K, Tang Y, Kong J, Chen Z, Fu J, Lin Q, Guo L, Wu Y, Li Y, Zhang J, Sun Z, You P, Zhang D, Chen Y, Lin X, Zhong C, Lin Z, Liu H, Huang Z, Zhou W, Dong P, Liu X, Zeng H, Qi X, Zeng Y
doi: 10.1136/gutjnl-2025-335449
Inflammatory Bowel Disease
DIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS WITH CROHN'S DISEASE: A SYSTEMATIC REVIEW
Clin Gastroenterol Hepatol
Cohen NA, Sror N, Naseer M, Bettenworth D, Lu C, Khedraki R, Abreu M, Atreya R, Al-Bawardy B, Connor SJ, d'Haens G, Dotan I, Dignass A, El Ouali S, Feagan B, Feakins R, Gearry R, Gordon IO, Hedin C, Kobayashi T, Leibovitzh H, Maharshak N, Ollech J, Sebastian S, Siegmund B, Rubin DT, Silverberg MS, Steinwurz F, Torres J, Watermeyer G, Hernandez-Rocha C, Gurizzian P, Silfen A, Tzadok R, Falloon K, Rieder F
doi: 10.1016/j.cgh.2025.03.024
Hepatitis
Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis
Hepatology
Li J, Xu L, Rui F, Tran S, Tsai PC, Tan Y, Toyoda H, Zeng QL, Trinh H, Hsu YC, Watanabe T, Abe H, Motoyama H, Yoshimaru Y, Suzuki T, Arai T, Atsukawa M, Vutien P, Marciano S, Bai X, Ni W, Geng N, Tseng CH, Liu J, Mi Y, Liu J, Ye Y, Zhu L, Chen RY, Zhu C, Maeda M, Liu JK, Henry L, Yeh ML, Huang CF, Huang JF, Dai CY, Gadano A, Cheung R, Chuang WL, Enomoto M, Tanaka Y, Aishima S, Yu ML, Wu C, Shi J, Nguyen MH
doi: 10.1097/HEP.0000000000001442
Further Publications
AGA Clinical Practice Guideline on Management of Gastroparesis
Gastroenterology
Staller K, Parkman HP, Greer KB, Leiman DA, Zhou MJ, Singh S, Camilleri M, Altayar O, AGA Clinical Guidelines Committee
doi: 10.1053/j.gastro.2025.08.004
Hepatitis
Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A REAL-B study
Am J Gastroenterol
Li J, Liu JK, Chau A, Linden S, Tsai PC, Nozaki A, Vutien P, Uojima H, Toyoda H, Honda T, Trinh H, Abe H, Ishikawa T, Atsukawa M, Watanabe T, Tsuji K, Huang DQ, Takaguchi K, Itobayashi E, Marciano S, Rui F, Ni W, Takahashi H, Chuang WL, Dai CY, Huang JF, Huang CF, Yeh ML, Zhu Y, Itokawa N, Kozuka R, Inoue K, Senoh T, Maeda M, Ito T, Morimoto M, Cheung R, Gadano A, Enomoto M, Tanaka Y, Lim SG, Wu C, Yu ML, Nguyen MH
doi: 10.14309/ajg.0000000000003881
Inflammatory Bowel Disease
AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease
Gastroenterology
Scott FI, Ananthakrishnan AN, Click B, Agrawal M, Syal G, Haydek JP, Yuan Y, Kappelman MD, Lewis JD, Singh S
doi: 10.1053/j.gastro.2025.09.038